[Treatment of herpes zoster infections in patients infected with HIV].
Breton
G
G
Bricaire
F
F
Caumes
E
E
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000284:Administration, Oral; D000998:Antiviral Agents / Q000627:therapeutic use*; D001682:Biological Availability; D018791:CD4 Lymphocyte Count; D004352:Drug Resistance, Microbial; D000077595:Famciclovir; D006562:Herpes Zoster / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000998:Antiviral Agents; D015075:2-Aminopurine; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir